The recommended treatment for DES implants is dual therapy of aspirin and plavix up to a year. Combining plavix and aspirin increases the risk of bleeding vs. aspirin alone in patients treated for more than a brief period of time. That is the regimen followed for my DES implant.
f you are in this category a prior MI and unstable angina:" In the CAPRIE trial, clopidogrel (plavix) was equivalent to aspirin for patients with a recent (but not acute) MI. Some subgroups of patients with cardiovascular disease in this trial seemed to benefit more from clopidogrel than from aspirin: those with a history of bypass surgery, a prior stroke or MI, arterial disease in two or more areas, diabetes, or high cholesterol. Clopidogrel may be a reasonable choice for these patients. Patients with a past history of MI within the prior 5 years don't seem to derive any more benefit from dual therapy.
In some disease states, clotting occurs when it shouldn’t. If you have been diagnosed with a Pulmonary Embolism (blood clot to the lung), Deep Vein Thrombosis (blood clot in the legs), certain cardiac disorders (artificial valves or arrhythmia’s) or clotting disorders, your physician may prescribe a regimen of Coumadin as therapy.
1.Use low-dose aspirin (81-162 mg/day) in these patients:
◦no known vascular disease but at high risk because of age and/or risk factors
◦stable angina
◦MI over 1 year previously and not at high risk of vascular events (none of the following): bypass surgery, events involving multiple vascular beds, >1 ischemic event, diabetes, or high cholesterol
◦stroke (acute or remote) but no other reason for having a high risk of vascular events
2.Use clopdiogrel (Plavix) alone (75 mg/day) in these patients:
◦allergic to aspirin (note: patients with a history of aspirin-induced gastrointestinal bleeding should receive aspirin plus a proton-pump inhibitor)
◦prior MI (over 1 year previous) or stroke, and at high risk of vascular events
◦peripheral vascular disease that is symptomatic or was surgically corrected.
.Use clopidogrel (Plavix) (75 mg/day) plus aspirin (81-162 mg/day) and re-assess after 1 year in these patients:
◦acute MI within past year
◦coronary stent insertion within past year.
Coumadin is another anti-platelet medication and is recommended for individuals that valve replacement.
It seems to me you are at a highly increased risk for excessive bleeding, and that may exceed the risk of clots, etc., but your doctor may consider you at a high risk for blood clot?!